Privi Speciality Chemicals Limited has announced an earnings conference call scheduled for May 12, 2026, to discuss the operational and financial performance for the fourth quarter and financial year ended March 31, 2026. The announcement was made pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and communicated to both BSE Limited and National Stock Exchange of India Limited.

Earnings Conference Call Details

The earnings call will be held on Tuesday, May 12, 2026, at 4.00 p.m. IST. The company has requested participants to pre-register for the call through a designated link. A transcript of the conference call will be available on the company's website at www.privi.com within five working days post conclusion of the call.

Management Team Participation

The management team participating in the earnings call includes key executives from the company:

• Mr. Mahesh Babani – Chairman and Managing Director
• Mr. R. S. Rajan – President
• Mr. Narayan Iyer – Chief Financial Officer
• Mr. Sanjeev Patil – Executive Vice President, Strategy and Biotechnology
• Ms. Ashwini Shah – Company Secretary and Compliance Officer

Board Meeting Context

The earnings call follows a board meeting scheduled for May 11, 2026, at Privi House, A-71, TTC, Thane Belapur Road, Koparkhairne, Navi Mumbai, Maharashtra. The board will consider the approval of audited standalone and consolidated financial results under Ind-AS for the quarter and financial year ended March 31, 2026, and deliberate on the declaration of final dividend on equity shares.

Trading Window Status

The trading window for designated persons and their immediate relatives remains closed effective April 01, 2026, and is scheduled to reopen on Thursday, May 14, 2026, as part of the company's insider trading prevention measures. The communications were signed by Company Secretary Ashwini Saunil Shah.

Privi Speciality Chemicals Limited has submitted its quarterly compliance certificate under SEBI regulations for the fourth quarter of fiscal year 2026. The submission demonstrates the company's adherence to regulatory requirements for securities dematerialisation processes.

Regulatory Compliance Submission

The company submitted the certificate under Regulation 74(5) of SEBI (Depository & Participants) Regulations, 2018 for the quarter ended March 31, 2026. Company Secretary Ashwini Saumil Shah signed and submitted the document on April 06, 2026, to both BSE Limited and National Stock Exchange of India Ltd.

Certificate Confirmation Details

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the Registrar and Share Transfer Agent for Privi Speciality Chemicals. The certificate confirms several key compliance aspects for the quarter:

• Securities received from depository participants for dematerialisation were confirmed (accepted/rejected) to depositories
• Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialisation were confirmed/rejected within prescribed timelines
• Security certificates were mutilated and cancelled after due verification by depository participants
• Names of depositories were substituted in the register of members as registered owners

Corporate Information

The company operates from its registered office at Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station, Navi Mumbai. Privi Speciality Chemicals holds multiple ISO certifications including ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018, reflecting its commitment to quality, environmental, and occupational health and safety management systems.

This quarterly submission represents standard regulatory compliance for listed companies, ensuring transparency in securities handling and dematerialisation processes as mandated by SEBI regulations.